Updates
Recent analytical updates across public coverage.
This page brings together the latest published analysis changes across the current 65-company coverage universe. Each item links back to the underlying company page.
Coverage snapshot
Report updated: Jun 15, 2026
Curated public preview analysis with live price, filing metadata, and reported fundamentals overlays. Full live filing ingestion is not yet enabled.
Coverage currently spans sixty-five companies: MSFT, NVDA, AAPL, GOOGL, AMZN, META, AVGO, ORCL, AMD, NFLX, V, MA, WMT, PG, JNJ, ADBE, CSCO, TXN, COST, KO, HD, PEP, QCOM, INTU, MCD, ADP, ABT, IBM, LOW, SBUX, NKE, DIS, AMAT, LRCX, MRK, PFE, TMO, ACN, NOW, PANW, SNPS, CDNS, ADI, HON, CAT, DE, UPS, BKNG, YUM, MDLZ, FDX, CMG, TGT, LULU, GILD, AMGN, REGN, ZTS, ISRG, SYK, DHR, CL, KMB, ROST, and TJX.
Latest updates
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on durable cash generation versus cyclical demand and leverage.
Initialized normalized annual model base
Impact: Creates a clean future LOW versus HD comparison without forcing a stronger rating.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on brand recovery potential versus still-unproven traffic and margin repair.
Initialized normalized annual model base
Impact: Adds a restaurant/consumer-brand comparison point while keeping the initial view evidence-led.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on brand turnaround optionality versus weak current revenue momentum.
Initialized normalized annual model base
Impact: Keeps the initial valuation grounded until the turnaround has cleaner evidence.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on recovery progress versus still-mixed segment and leverage risk.
Initialized normalized annual model base
Impact: Adds a high-interest media name while keeping valuation support tied to cash-flow evidence.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on strong equipment economics versus a premium cycle-aware valuation.
Initialized normalized annual model base
Impact: Sets up a clean AMAT versus LRCX comparison while avoiding an aggressive cycle call.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on strong process-equipment economics versus cycle and valuation risk.
Initialized normalized annual model base
Impact: Creates a direct semiconductor-equipment pair without forcing a cycle-timing call.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on strong pharma cash flow versus pipeline and concentration risk.
Initialized normalized annual model base
Impact: Adds a mature pharma anchor while avoiding specialized health-care model complexity.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on low-multiple support versus leverage and growth-reset risk.
Initialized normalized annual model base
Impact: Adds a pharma reset case without letting low headline multiples overstate conviction.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on high-quality life-sciences cash generation versus uneven near-term demand.
Initialized normalized annual model base
Impact: Adds a clean health-care tools compounder without requiring a special accounting model.
Added to AnalystScope coverage
Impact: Started coverage with a constructive but measured view on cash conversion and enterprise transformation exposure.
Initialized normalized annual model base
Impact: Adds a clean services anchor for software/IT-spend comparisons without introducing special accounting complexity.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on excellent software economics versus premium valuation sensitivity.
Initialized normalized annual model base
Impact: Adds a high-quality software compounder while keeping upside assumptions guarded.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on strong security demand versus platform-transition and valuation risk.
Initialized normalized annual model base
Impact: Adds a cybersecurity anchor while avoiding an aggressive growth-stock rating.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on exceptional EDA quality versus a full valuation.
Initialized normalized annual model base
Impact: Creates a useful future SNPS versus CDNS pair without forcing a premium-growth call.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on high-quality EDA exposure versus premium valuation.
Initialized normalized annual model base
Impact: Completes a clean initial EDA pair with Synopsys.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on high-quality analog economics versus cycle timing risk.
Initialized normalized annual model base
Impact: Adds a cleaner analog semiconductor anchor without stretching into more volatile memory or commodity exposure.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on industrial quality versus portfolio-transition complexity.
Initialized normalized annual model base
Impact: Adds a diversified industrial anchor without adding financial-sector complexity.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on strong industrial execution versus cycle normalization risk.
Initialized normalized annual model base
Impact: Adds a high-search industrial bellwether with explicit caution around cycle and financial-services debt.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on quality machinery economics versus agriculture-cycle risk.
Initialized normalized annual model base
Impact: Creates a useful CAT versus DE future comparison with explicit captive-finance caution.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on recovery potential versus still-muted volume and margin evidence.
Initialized normalized annual model base
Impact: Adds a logistics bellwether while keeping the initial valuation disciplined.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on strong travel marketplace economics versus cyclicality and valuation.
Initialized normalized annual model base
Impact: Adds a high-search consumer internet name without building a new platform model.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on franchise quality versus leverage and valuation.
Initialized normalized annual model base
Impact: Adds a clean restaurant-franchise comparator to MCD and SBUX.
Added to AnalystScope coverage
Impact: Started coverage with a constructive view on defensive brand cash flow and moderate upside.
Initialized normalized annual model base
Impact: Adds a clean consumer-staples peer to PG, KO, and PEP without expanding into special sectors.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on logistics recovery potential versus still-needed margin proof.
Initialized normalized annual model base
Impact: Creates a direct UPS versus FDX future comparison without forcing a turnaround call.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on exceptional restaurant quality versus premium valuation.
Initialized normalized annual model base
Impact: Adds a high-interest restaurant growth name while keeping valuation discipline.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on recovery potential versus consumer and margin uncertainty.
Initialized normalized annual model base
Impact: Adds a clean future TGT versus WMT comparison.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on brand quality versus growth normalization risk.
Initialized normalized annual model base
Impact: Adds a premium apparel growth name while avoiding a story-stock valuation posture.
Added to AnalystScope coverage
Impact: Started coverage with a constructive view on cash-flow support versus modest expectations.
Initialized normalized annual model base
Impact: Adds a mature biopharma anchor for future GILD versus AMGN comparison.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on cash-flow quality versus leverage and pipeline uncertainty.
Initialized normalized annual model base
Impact: Adds a mature biopharma peer to Gilead with explicit leverage caution.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on high-quality biopharma economics versus concentration risk.
Initialized normalized annual model base
Impact: Adds a profitable biotech quality name while keeping pipeline risk explicit.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on animal-health quality versus a full valuation.
Initialized normalized annual model base
Impact: Adds a cleaner health-care compounder without needing bank or insurer-style modeling.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on excellent medtech quality versus premium valuation.
Initialized normalized annual model base
Impact: Adds a high-interest medtech name with explicit caution around premium assumptions.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on durable medtech execution versus a quality multiple.
Initialized normalized annual model base
Impact: Adds a clean medtech compounder without forcing a stronger rating.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on quality tools exposure versus recovery timing.
Initialized normalized annual model base
Impact: Adds a life-sciences tools peer while keeping demand-recovery risk explicit.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on defensive brand quality versus full valuation.
Initialized normalized annual model base
Impact: Creates a clean CL versus KMB future comparison.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on defensive cash flow versus low growth.
Initialized normalized annual model base
Impact: Completes a clean household-products pair with Colgate-Palmolive.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on off-price quality versus fair valuation.
Initialized normalized annual model base
Impact: Creates a useful ROST versus TJX future comparison.
Added to AnalystScope coverage
Impact: Started coverage with a Hold view on global off-price quality versus a full multiple.
Initialized normalized annual model base
Impact: Completes the initial ROST versus TJX off-price comparison pair.
Added to AnalystScope coverage
Impact: New Hold view on quality retail with cyclical moderation
Kept housing-cycle assumptions conservative
Impact: Avoids overstating upside from a single rebound year
Added to AnalystScope coverage
Impact: New Hold view on defensive branded-consumer quality
Kept balance-sheet treatment conservative
Impact: Avoids overstating distributable-cash support
Added to AnalystScope coverage
Impact: New Buy view on cycle-normalized valuation support
Kept licensing and cycle assumptions conservative
Impact: Avoids overstating upside from a single recovery leg
Added to AnalystScope coverage
Impact: New Hold view on durable software quality
Kept valuation assumptions disciplined
Impact: Avoids overstating upside from a premium multiple base
Added to AnalystScope coverage
Impact: New Hold view on franchise quality with a still-contained spread to fair value
Kept balance-sheet treatment conservative
Impact: Avoids overstating upside from a leveraged but durable cash generator
Added to AnalystScope coverage
Impact: New Hold view on durable payroll-and-HCM economics
Kept balance-sheet treatment conservative
Impact: Avoids overstating support from client-funds-related cash balances
Added to AnalystScope coverage
Impact: New Hold view on diversified healthcare durability
Kept valuation framing disciplined
Impact: Avoids overstating upside from a still-contained spread to fair value
Added to AnalystScope coverage
Impact: New Hold view on steadier enterprise execution versus a moderate valuation spread
Kept debt treatment conservative
Impact: Avoids overstating upside from improving operations alone
Added to AnalystScope coverage
Impact: New Buy view after a cleaner multiple reset
Kept valuation anchored to conservative software multiples
Impact: Avoids assuming a full return to prior peak sentiment
Added to AnalystScope coverage
Impact: New Hold view on steady infrastructure quality
Kept hardware-cycle assumptions conservative
Impact: Avoids overstating upside from a single replacement wave
Added to AnalystScope coverage
Impact: New Hold view on analog quality through the cycle
Kept capex assumptions conservative
Impact: Avoids overstating free-cash-flow recovery
Added to AnalystScope coverage
Impact: New Hold view on premium-quality retail economics
Kept multiple assumptions disciplined
Impact: Avoids overstating upside from an already expensive base
Added to AnalystScope coverage
Impact: New Hold view on durable beverage economics
Kept leverage treatment conservative
Impact: Avoids overstating distributable-cash support
Added to AnalystScope coverage
Impact: New Hold view at current valuation spread
Set conservative settlement-float treatment
Impact: Keeps balance-sheet support restrained
Added to AnalystScope coverage
Impact: New Buy view based on durable payment economics
Anchored valuation on moderate premium multiples
Impact: Avoids overstating quality-premium upside
Added to AnalystScope coverage
Impact: New Hold view on steady quality with moderate upside
Kept FCF treatment conservative
Impact: Avoids overstating cash conversion from inventory timing
Added to AnalystScope coverage
Impact: New Hold view on durable staples quality
Kept margin normalization conservative
Impact: Avoids overstating recent pricing-driven strength
Added to AnalystScope coverage
Impact: New Hold view on diversified healthcare resilience
Used conservative balance-sheet treatment
Impact: Keeps distributable-cash assumptions restrained
Raised ad monetization assumptions after stronger Reels checks
Impact: +1.8% base case
Lowered multiple support after valuation rerating
Impact: -2.0% fair value
Raised AI networking mix assumptions
Impact: +1.1% fair value
Raised server share-gain assumptions modestly
Impact: +0.9% fair value
Raised OCI backlog conversion in the base case
Impact: +1.4% fair value
Cloud margin assumptions increased after channel checks
Impact: +1.7% valuation uplift
Services growth assumptions lifted after mixed device checks
Impact: +1.0% base case
AWS backlog assumptions revised higher
Impact: +2.0% target revision
Azure growth re-accelerated in channel checks
Impact: +2.4% target revision
Lifted AI infrastructure spend in outer years
Impact: -0.7% DCF fair value
Street estimates revised up after hyperscaler commentary
Impact: +3.0% base case
Raised AI monetization contribution in Search model
Impact: +0.9% EPS outlook
Raised ad monetization contribution modestly
Impact: +0.6% EPS outlook
Raised AI capex assumptions
Impact: -1.1% DCF fair value
Maintained conservative deleveraging path
Impact: Caps upside multiple expansion
Maintained cautious AI accelerator adoption curve
Impact: Keeps rating at Hold
Adjusted iPhone replacement-cycle forecast lower
Impact: -0.8% revenue estimate
Lifted capex assumptions for cloud infrastructure
Impact: -0.5% FCF outlook
Supply constraints eased for networking components
Impact: +1.2% gross margin
North America retail margin forecast increased
Impact: +80 bps operating margin
Improved messaging monetization contribution
Impact: +0.6% EPS outlook
Regulatory discount maintained in bear case
Impact: Caps multiple expansion
Maintained stronger free-cash-flow conversion assumptions
Impact: Supports downside floor
Capital return outlook extended in model
Impact: Supportive for valuation floor
Improved software synergy capture assumptions
Impact: +0.5% FCF outlook
Improved margin mix assumptions for data center
Impact: +40 bps operating margin
Improved Office commercial renewal trends
Impact: +0.9% EPS uplift
Improved support revenue durability assumptions
Impact: Supports margin resilience
Advertising growth sensitivity widened in bull case
Impact: Improves upside skew
Higher valuation multiple sensitivity applied
Impact: Increased downside scenario